TCR specificity dictates CD94/NKG2A expression by human CTL

Immunity

Volumn 17, Issue 4, 2002, Pages 487-499

  Jabri, Bana ^a   Selby, Jeanette M ^b   Negulescu, Horia ^a   Lee, Leanne ^a   Roberts, Arthur I ^c   Beavis, Andrew ^a   Lopez Botet, Miguel ^d   Ebert, Ellen C ^c   Winchester, Robert J ^b  

^a PRINCETON UNIVERSITY   (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; LECTIN; RECEPTOR PROTEIN; RECEPTOR PROTEIN NKG2A; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD; CELL CLONE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0036799629     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00427-2     Document Type: Article

References (46)

1. Arden B., Clark S.P., Kabelitz D., Mak T.W. Human T-cell receptor variable gene segment families. Immunogenetics. 42:1995;455-500.
2. Arstila T.P., Casrouge A., Baron V., Even J., Kanellopoulos J., Kourilsky P. A direct estimate of the human αβ T cell receptor diversity. Science. 286:1999;958-961.
3. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-729.
4. + T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. J. Immunol. 162:1999;3996-4002.
5. Bloom S., Simmons D., Jewell D.P. Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin. Exp. Immunol. 101:1995;157-163.
6. Blumberg R.S., Yockey C.E., Gross G.G., Ebert E.C., Balk S.P. Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple Vβ T cell receptor genes. J. Immunol. 150:1993;5144-5153.
7. Bourcier K.D., Lim D.G., Ding Y.H., Smith K.J., Wucherpfennig K., Hafler D.A. Conserved CDR3 regions in T-cell receptor (TCR) CD8+ T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1. relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure J. Virol. 75:2001;9836-9843.
8. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H.et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
9. Casanova J.L., Maryanski J.L. Antigen-selected T-cell receptor diversity and self-nonself homology. Immunol. Today. 14:1993;391-394.
10. Colonna M., Moretta A., Vely F., Vivier E. A high-resolution view of NK-cell receptors. structure and function Immunol. Today. 21:2000;428-431.
11. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., Kubin M., Chalupny N.J. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 14:2001;123-133.
12. Costello P.J., Winchester R.J., Curran S.A., Peterson K.S., Kane D.J., Bresnihan B., FitzGerald O.M. Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J. Immunol. 166:2001;2878-2886.
13. Glusman G., Rowen L., Lee I., Boysen C., Roach J.C., Smit A.F., Wang K., Koop B.F., Hood L. Comparative genomics of the human and mouse T cell receptor loci. Immunity. 15:2001;337-349.
14. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Ridell S.R., Spies T. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2:2001;255-260.
15. Jabri B., de Serre N.P., Cellier C., Evans K., Gache C., Carvalho C., Mougenot J.F., Allez M., Jian R., Desreumaux P.et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology. 118:2000;867-879.
16. Kalams S.A., Johnson R.P., Trocha A.K., Dynan M.J., Ngo H.S., D'Aquila R.T., Kurnick J.T., Walker B.D. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1994;1261-1271.
17. Lanier L.L., Phillips J.H. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today. 17:1996;86-91.
18. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA. 95:1998;5199-5204.
19. Long E.O., Burshtyn D.N., Clark W.P., Peruzzi M., Rajagopalan S., Rojo S., Wagtmann N., Winter C.C. Killer cell inhibitory receptors. diversity, specificity, and function Immunol. Rev. 155:1997;135-144.
20. Lopez-Botet M., Llano M., Navarro F., Bellon T. NK cell recognition of non-classical HLA class I molecules. Semin. Immunol. 12:2000;109-119.
21. Mackensen A., Carcelain G., Viel S., Raynal M.C., Michalaki H., Triebel F., Bosq J., Hercend T. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest. 93:1994;1397-1402.
22. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
23. McHeyzer-Williams L.J., Panus J.F., Mikszta J.A., McHeyzer-Williams M.G. Evolution of antigen-specific T cell receptors in vivo. preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs J. Exp. Med. 189:1999;1823-1838.
24. Medzhitov R., Janeway C.A. Jr. How does the immune system distinguish self from nonself? Semin. Immunol. 12:2000;185-188. discussion 257-344.
25. Moretta A., Moretta L. HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 9:1997;694-701.
26. Moser J.M., Gibbs J., Jensen P.E., Lukacher A.E. CD94-NKG2A receptors regulate antiviral CD8+ T cell responses. Nat. Immunol. 3:2002;189-195.
27. Namekawa T., Snyder M.R., Yen J.H., Goehring B.E., Leibson P.J., Weyand C.M., Goronzy J.J. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 165:2000;1138-1145.
28. Perez-Villar J.J., Melero I., Rodriguez A., Carretero M., Aramburu J., Sivori S., Orengo A.M., Moretta A., Lopez-Botet M. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 154:1995;5779-5788.
29. Perkins D., Wang Z., Donovan C., He H., Mark D., Guan G., Wang Y., Walunas T., Bluestone J., Listman J.et al. Regulation of CTLA-4 expression during T cell activation. J. Immunol. 156:1996;4154-4159.
30. Pietra G., Romagnani C., Falco M., Vitale M., Castriconi R., Pende D., Millo E., Anfossi S., Biassoni R., Moretta L., Mingari M.C. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR α/β-mediated recognition. Eur. J. Immunol. 31:2001;3687-3693.
31. Raulet D.H., Vance R.E., McMahon C.W. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19:2001;291-330.
32. Roberts A.I., Lee L., Schwarz E., Groh V., Spies T., Ebert E.C., Jabri B. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167:2001;5527-5530.
33. Rowen L., Koop B.F., Hood L. The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science. 272:1996;1755-1762.
34. Sant'Angelo D.B., Waterbury P.G., Cohen B.E., Martin W.D., Van Kaer L., Hayday A.C., Janeway C.A. Jr. The imprint of intrathymic self-peptides on the mature T cell receptor repertoire. Immunity. 7:1997;517-524.
35. Schatzle J.D., Sheu S., Stepp S.E., Mathew P.A., Bennett M., Kumar V. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc. Natl. Acad. Sci. USA. 96:1999;3870-3875.
36. Smith H.R., Chuang H.H., Wang L.L., Salcedo M., Heusel J.W., Yokoyama W.M. Nonstochastic coexpression of activation receptors on murine natural killer cells. J. Exp. Med. 191:2000;1341-1354.
37. Speiser D.E., Pittet M.J., Valmori D., Dunbar R., Rimoldi D., Lienard D., MacDonald H.R., Cerottini J.C., Cerundolo V., Romero P. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 190:1999;775-782.
38. Steinman R.M., Turley S., Mellman I., Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:2000;411-416.
39. Taunk J., Roberts A.I., Ebert E.C. Spontaneous cytotoxicity of human intraepithelial lymphocytes against epithelial cell tumors. Gastroenterology. 102:1992;69-75.
40. Ugolini S., Vivier E. Multifaceted roles of MHC class I and MHC class I-like molecules in T cell activation. Nat. Immunol. 2:2001;198-200.
41. Uhrberg M., Valiante N.M., Young N.T., Lanier L.L., Phillips J.H., Parham P. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells. clones sharing identical αβ TCR rearrangement express highly diverse killer cell Ig-like receptor patterns J. Immunol. 166:2001;3923-3932.
42. Van Kerckhove C., Russell G.J., Deusch K., Reich K., Bhan A.K., DerSimonian H., Brenner M.B. Oligoclonality of human intestinal intraepithelial T cells. J. Exp. Med. 175:1992;57-63.
43. Vely F., Peyrat M., Couedel C., Morcet J., Halary F., Davodeau F., Romagne F., Scotet E., Saulquin X., Houssaint E.et al. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 166:2001;2487-2494.
44. Vie H., Chevalier S., Garand R., Moisan J., Praloran V., Devilder M., Moreau J., Soulillou J. Clonal expansion of lymphocytes bearing the γ-δ-T-cell-receptor in a patient with large granular lymphocyte disorder. Blood. 74:1989;285-290.
45. Yang Y., Charlton B., Shimada A., Dal Canto R., Fathman C.G. Monoclonal T cells identified in early NOD islet infiltrates. Immunity. 4:1996;189-194.
46. Zajac A.J., Vance R.E., Held W., Sourdive D.J., Altman J.D., Raulet D.H., Ahmed R. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J. Immunol. 163:1999;5526-5534.